SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001319244-15-000030
Filing Date
2015-07-14
Accepted
2015-07-14 16:53:26
Documents
1
Group Members
ICS OPPORTUNITIES, LTD.INTEGRATED ASSETS, LTD.INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM INTERNATIONAL MANAGEMENT GP LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 AAVL_sc13g.htm SC 13G 140657
  Complete submission text file 0001319244-15-000030.txt   142661
Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

IRS No.: 202196675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88266 | Film No.: 15987752
SIC: 2836 Biological Products, (No Diagnostic Substances)